Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19

Lucas C Godoy; Ewan C Goligher; Patrick R Lawler; Arthur S Slutsky; Ryan Zarychanski

doi:10.1503/cmaj.201240

Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19

CMAJ. 2020 Oct 5;192(40):E1156-E1161. doi: 10.1503/cmaj.201240. Epub 2020 Aug 16.

Authors

Lucas C Godoy¹, Ewan C Goligher¹, Patrick R Lawler², Arthur S Slutsky¹, Ryan Zarychanski¹

Affiliations

¹ Peter Munk Cardiac Centre (Godoy, Lawler), University of Toronto, Toronto, Ont.; Instituto do Coracao (Godoy), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil; Interdepartmental Division of Critical Care Medicine (Goligher, Lawler, Slutsky), University of Toronto; Division of Respirology (Goligher), Department of Medicine, University Health Network; Toronto General Hospital Research Institute (Goligher, Lawler); Keenan Research Center (Slutsky), Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ont.; Max Rady Faculty of Health Sciences, Max Rady College of Medicine (Zarychanski), Department of Internal Medicine, University of Manitoba; Research Institute in Oncology and Hematology (Zarychanski), CancerCare Manitoba, Winnipeg, Man.
² Peter Munk Cardiac Centre (Godoy, Lawler), University of Toronto, Toronto, Ont.; Instituto do Coracao (Godoy), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil; Interdepartmental Division of Critical Care Medicine (Goligher, Lawler, Slutsky), University of Toronto; Division of Respirology (Goligher), Department of Medicine, University Health Network; Toronto General Hospital Research Institute (Goligher, Lawler); Keenan Research Center (Slutsky), Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ont.; Max Rady Faculty of Health Sciences, Max Rady College of Medicine (Zarychanski), Department of Internal Medicine, University of Manitoba; Research Institute in Oncology and Hematology (Zarychanski), CancerCare Manitoba, Winnipeg, Man. [email protected].

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Anticoagulants / therapeutic use
Betacoronavirus*
Blood Coagulation Disorders / etiology
COVID-19
Coronavirus Infections / complications*
Coronavirus Infections / therapy
Critical Illness
Humans
Monitoring, Physiologic
Pandemics
Pneumonia, Viral / complications*
Pneumonia, Viral / therapy
SARS-CoV-2
Thrombosis / etiology*
Thrombosis / prevention & control
Venous Thromboembolism / etiology*
Venous Thromboembolism / prevention & control

Substances

Anticoagulants